Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Research & Development (2023 - 2025)

Historic Research & Development for Biofrontera (BFRI) over the last 3 years, with Q3 2025 value amounting to $854000.0.

  • Biofrontera's Research & Development rose 2765.32% to $854000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 17716.42%. This contributed to the annual value of $2.1 million for FY2024, which is 261298.7% up from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Research & Development is $854000.0, which was up 2765.32% from $870000.0 recorded in Q2 2025.
  • Biofrontera's Research & Development's 5-year high stood at $1.2 million during Q1 2025, with a 5-year trough of $11000.0 in Q2 2023.
  • Moreover, its 3-year median value for Research & Development was $645000.0 (2024), whereas its average is $509800.0.
  • Over the last 5 years, Biofrontera's Research & Development had its largest YoY gain of 700000.0% in 2025, and its largest YoY loss of 2765.32% in 2025.
  • Over the past 3 years, Biofrontera's Research & Development (Quarter) stood at $33000.0 in 2023, then soared by 2272.73% to $783000.0 in 2024, then grew by 9.07% to $854000.0 in 2025.
  • Its Research & Development stands at $854000.0 for Q3 2025, versus $870000.0 for Q2 2025 and $1.2 million for Q1 2025.